NELTIRGA

Serial Number 98575364
730

Registration Progress

Application Filed
May 29, 2024
Under Examination
Nov 26, 2024
Approved for Publication
Oct 15, 2024
Published for Opposition
Oct 15, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 26, 2025 21 days

Trademark Image

NELTIRGA

Basic Information

Serial Number
98575364
Filing Date
May 29, 2024
Published for Opposition
October 15, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Apr 22, 2025
Application
Pending
Classes
005

Rights Holder

Johnson & Johnson

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

Johnson & Johnson

Original Applicant
03
New Brunswick, NJ

Johnson & Johnson

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Danielle Rivera

USPTO Deadlines

Next Deadline
21 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025

Application History

12 events
Date Code Type Description Documents
Apr 23, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 22, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 22, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 22, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 15, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 15, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 11, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 11, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 30, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers

Classification

International Classes
005